Physician

Casmiar I Nwaigwe, MD

According to 2025 Medicare claims, Casmiar Nwaigwe, MD (NPI: 1902832041) practices infectious disease in the Minot, ND market, with the plurality of this provider's patient population coming from Ward, ND. This provider's primary affiliated billing organization is TRINITY HEALTH (NPI: 1083653752; TIN: 450226558) and primary practice location at 58701-7669. Nwaigwe is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Nwaigwe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 352 traditional Medicare patients, billed 1,600 HCPCS/CPT codes, and received $116,163 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,929 prescription claims across 1,156 beneficiaries totaling $627,078 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2020 DME data shows 12 claims. Open Payments data shows 31 records totaling $68,277. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $520,594 and ending at $627,078. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $966 and ending at $4,130.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	413	2,156	$132,886
2016	412	2,520	$146,870
2017	407	2,242	$137,626
2018	464	2,848	$171,428
2019	460	2,667	$173,592
2020	534	3,243	$209,840
2021	479	3,021	$182,307
2022	389	2,518	$151,083
2023	337	1,688	$116,035
2024	352	1,600	$116,163

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	88	346	$520,594
2016	185	606	$1,165,766
2017	195	514	$693,710
2018	722	1,579	$917,129
2019	835	1,689	$854,459
2020	477	1,088	$634,836
2021	371	854	$406,602
2022	363	830	$381,496
2023	1,583	2,464	$970,683
2024	1,156	1,929	$627,078

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	15	$4,656
2019	N/R	15	$3,946
2020	N/R	12	$179
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	127	135	$131
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	117	127	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	72	154	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	110	283	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	178	659	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	46	1,380	$178,582
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	419	3,725	$133,991
Arexvy	Rsvpref3 Antigen/As01e/Pf	274	2,536	$85,147
Shingrix	Varicella-Zoster Ge/As01b/Pf	360	3,492	$79,410
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	15	450	$53,670

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$6,395	Melinta Therapeutics, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$61,881	Daiichi Sankyo Company LTD
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Casmiar I. Nwaigwe, MD?

Tedicare shows public-source Medicare data for Casmiar I. Nwaigwe, MD (NPI 1902832041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Casmiar I. Nwaigwe, MD have ACO affiliation data?

Casmiar I. Nwaigwe, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Casmiar I. Nwaigwe, MD?

Casmiar I. Nwaigwe, MD is linked to TRINITY HEALTH (billing NPI 1083653752) in the available physician profile data.

Does Casmiar I. Nwaigwe, MD have Open Payments data?

Casmiar I. Nwaigwe, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.